CRISPR/Cas12a2 enables ultra-sensitive amplification-free RNA detection
Nucleic Acids Research · 13.11.2025 · 53 (21)
DOI: 10.1093/nar/gkaf1293 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 24.11.2025. Verfasst von Hyowon Jang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Bionanotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Republic of Korea. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, RNA, Viral, SARS-CoV-2, CRISPR-Associated Proteins. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, Korea Evaluation Institute of Industrial Technology.
Abstract (Originalsprache)
Advances in clustered regularly interspaced short palindromic repeat (CRISPR) technologies have led to the use of diverse CRISPR-associated (Cas) proteins in diagnostic applications. Herein, we present a CRISPR/Cas12a2-based amplification-free RNA detection method that exhibits sub-attomolar sensitivity and substrate versatility. Cas12a2, a recently characterized RNA-guided nuclease, uniquely integrates bimolecular recognition through CRISPR RNA (crRNA)-target complementarity and protospacer flanking sequence identification, enabling highly specific trans-cleavage of single-stranded DNA, double-stranded DNA, and RNA. We have optimized key biochemical parameters, including pH, ionic strength, and temperature, to enhance the catalytic efficiency of Cas12a2. Based on the optimal activity conditions of Cas12a2, we have achieved ultra-sensitive viral RNA detection with a limit of detection of 46.7 aM through the strategic design and cooperative activation of crRNAs targeting conserved regions of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome. The diagnostic accuracy of the Cas12a2-based assay has been demonstrated for 26 SARS-CoV-2 variants, and it has further resulted in the definitive diagnosis of 317 clinical samples. This work establishes Cas12a2 as a promising molecular diagnostic tool that provides an amplification-free, rapid, and versatile solution for RNA detection. The adaptability and simplicity of the platform render it particularly well suited for point-of-care applications, paving the way for next-generation CRISPR diagnostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Bionanotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Republic of Korea.
- Critical Diseases Diagnostics Convergence Research Center, KRIBB, Daejeon 34141, Republic of Korea.
- Department of Proteome Structural Biology, KRIBB School of Bioscience, University of Science and Technology (UST), Daejeon 34113, Republic of Korea.
- Department of Chemistry, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.
- Department of Laboratory Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju 52727, Republic of Korea.
- Department of Nanobiotechnology, KRIBB School of Biotechnology, UST, Daejeon 34113, Republic of Korea.
ORCID-Profile: Eun-Kyung Lim, Juyeon Jung, Eui-Jeon Woo, Taejoon Kang
Förderung
- National Research Foundation of Korea
- Ministry of Science and ICT
- Korea Evaluation Institute of Industrial Technology
- Ministry of Trade, Industry and Energy
- Korea Environmental Industry and Technology Institute
- Ministry of Environment
- Korea Health Industry Development Institute
- Ministry of Health and Welfare
Zitieren
APA
Jang, H., Kang, J. E., Kim, H., Kim, J. R., Park, J., Go, S. R., Lee, Y. H., Kang, H., Park, Y., Kim, S., Jung, Y., Kim, S. J., Lim, E. K., Jung, J., Woo, E. J., Park, K. H., & Kang, T. (2025). CRISPR/Cas12a2 enables ultra-sensitive amplification-free RNA detection. Nucleic Acids Research, 53(21). https://doi.org/10.1093/nar/gkaf1293
Vancouver
Jang H, Kang JE, Kim H, Kim JR, Park J, Go SR, et al. CRISPR/Cas12a2 enables ultra-sensitive amplification-free RNA detection. Nucleic Acids Research. 2025;53(21). doi:10.1093/nar/gkaf1293
BibTeX
@article{Jang2025,
author = {Jang, Hyowon and Kang, Ju-Eun and Kim, Hansol and Kim, Jae-Rin and Park, Junsoo and Go, Seong-Ryeong and Lee, Young-Hoon and Kang, Hyunju and Park, Yeonkyung and Kim, Sunjoo and Jung, Yongwon and Kim, Seung Jun and Lim, Eun-Kyung and Jung, Juyeon and Woo, Eui-Jeon and Park, Kwang-Hyun and Kang, Taejoon},
title = {CRISPR/Cas12a2 enables ultra-sensitive amplification-free RNA detection},
journal = {Nucleic Acids Research},
year = {2025},
volume = {53},
number = {21},
doi = {10.1093/nar/gkaf1293}
}
EUVIMED